A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges

A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges

© 2023 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 13 vom: 28. März, Seite e2310886
1. Verfasser: Cheng, Xingdi (VerfasserIn)
Weitere Verfasser: Liu, Sujia, Sun, Jing, Liu, Lin, Ma, Xinghuan, Li, Jingjiao, Fan, Bangda, Yang, Chen, Zhao, Yuanyuan, Liu, Shuai, Wen, Yixing, Li, Wei, Sun, Simin, Mi, Shiwei, Huo, Haonan, Miao, Lei, Pan, Hao, Cui, Xiaolan, Lin, Jiaqi, Lu, Xueguang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article glycoprotein lipid nanoparticle mRNA shingles vaccines Herpes Zoster Vaccine Lipid Nanoparticles Nanovaccines Adjuvants, Immunologic Liposomes
LEADER 01000caa a22002652 4500
001 NLM366362224
003 DE-627
005 20240330000704.0
007 cr uuu---uuuuu
008 231227s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202310886  |2 doi 
028 5 2 |a pubmed24n1355.xml 
035 |a (DE-627)NLM366362224 
035 |a (NLM)38145557 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Cheng, Xingdi  |e verfasserin  |4 aut 
245 1 2 |a A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 29.03.2024 
500 |a Date Revised 29.03.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2023 Wiley‐VCH GmbH. 
520 |a Shingles is caused by the reactivation of varicella zoster virus (VZV) and manifests as painful skin rashes. While the recombinant protein-based vaccine proves highly effective, it encounters supply chain challenges due to a shortage of the necessary adjuvant. Messenger RNA (mRNA)-based vaccines can be rapidly produced on a large scale, but their effectiveness relies on efficient delivery and sequence design. Here, an mRNA-based VZV vaccine using a synergistic lipid nanoparticle (Syn-LNP) containing two different ionizable lipids is developed. Syn-LNP shows superior mRNA expression compared to LNPs formulated with either type of ionizable lipid and to a commercialized LNP. After encapsulating VZV glycoprotein E (gE)-encoding mRNA, mgESyn-LNP induces robust humoral and cellular immune responses in two strains of mice. The magnitude of these responses is similar to that induced by adjuvanted recombinant gE proteins and significantly higher than that observed with live-attenuated VZV. mgE@Syn-LNP exhibits durable humoral responses for over 7 months without obvious adverse effects. In addition, mgE@Syn-LNP protects vaccinated guinea pigs against live VZV challenges. Preliminary studies on the mRNA antigen design reveal that the removal of glycosylation sites of gE greatly reduces its immune responses. Collectively, Syn-LNP encapsulating gE-encoded mRNA holds great promise as a shingles vaccine 
650 4 |a Journal Article 
650 4 |a glycoprotein 
650 4 |a lipid nanoparticle 
650 4 |a mRNA 
650 4 |a shingles vaccines 
650 7 |a Herpes Zoster Vaccine  |2 NLM 
650 7 |a Lipid Nanoparticles  |2 NLM 
650 7 |a Nanovaccines  |2 NLM 
650 7 |a Adjuvants, Immunologic  |2 NLM 
650 7 |a Liposomes  |2 NLM 
700 1 |a Liu, Sujia  |e verfasserin  |4 aut 
700 1 |a Sun, Jing  |e verfasserin  |4 aut 
700 1 |a Liu, Lin  |e verfasserin  |4 aut 
700 1 |a Ma, Xinghuan  |e verfasserin  |4 aut 
700 1 |a Li, Jingjiao  |e verfasserin  |4 aut 
700 1 |a Fan, Bangda  |e verfasserin  |4 aut 
700 1 |a Yang, Chen  |e verfasserin  |4 aut 
700 1 |a Zhao, Yuanyuan  |e verfasserin  |4 aut 
700 1 |a Liu, Shuai  |e verfasserin  |4 aut 
700 1 |a Wen, Yixing  |e verfasserin  |4 aut 
700 1 |a Li, Wei  |e verfasserin  |4 aut 
700 1 |a Sun, Simin  |e verfasserin  |4 aut 
700 1 |a Mi, Shiwei  |e verfasserin  |4 aut 
700 1 |a Huo, Haonan  |e verfasserin  |4 aut 
700 1 |a Miao, Lei  |e verfasserin  |4 aut 
700 1 |a Pan, Hao  |e verfasserin  |4 aut 
700 1 |a Cui, Xiaolan  |e verfasserin  |4 aut 
700 1 |a Lin, Jiaqi  |e verfasserin  |4 aut 
700 1 |a Lu, Xueguang  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 13 vom: 28. März, Seite e2310886  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:36  |g year:2024  |g number:13  |g day:28  |g month:03  |g pages:e2310886 
856 4 0 |u http://dx.doi.org/10.1002/adma.202310886  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 13  |b 28  |c 03  |h e2310886